An open-access mobile compatible electronic patient register for rheumatic heart disease (‘eRegister’) based on the World Heart Federation’s framework for patient registers

Summary Background Rheumatic heart disease (RHD) remains a major disease burden in low-resource settings globally. Patient registers have long been recognised to be an essential instrument in RHD control and elimination programmes, yet to date rely heavily on paper-based data collection and non-networked data-management systems, which limit their functionality. Objectives To assess the feasibility and potential benefits of producing an electronic RHD patient register. Methods We developed an eRegister based on the World Heart Federation’s framework for RHD patient registers using CommCare, an open-source, cloud-based software for health programmes that supports the development of customised data capture using mobile devices. Results The resulting eRegistry application allows for simultaneous data collection and entry by field workers using mobile devices, and by providers using computer terminals in clinics and hospitals. Data are extracted from CommCare and are securely uploaded into a cloud-based database that matches the criteria established by the WHF framework. The application can easily be tailored to local needs by modifying existing variables or adding new ones. Compared with traditional paper-based data-collection systems, the eRegister reduces the risk of data error, synchronises in real-time, improves clinical operations and supports management of field team operations. Conclusions The user-friendly eRegister is a low-cost, mobile, compatible platform for RHD treatment and prevention programmes based on materials sanctioned by the World Heart Federation. Readily adaptable to local needs, this paperless RHD patient register program presents many practical benefits.

[1]  P. Soulié,et al.  RHEUMATIC HEART DISEASE , 1954, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.

[2]  C. Mondo,et al.  Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital , 2013, Cardiovascular journal of Africa.

[3]  B. Currie,et al.  Acute rheumatic fever: adherence to secondary prophylaxis and follow up of Indigenous patients in the Katherine region of the Northern Territory. , 2007, The Australian journal of rural health.

[4]  Phalla Ou,et al.  Prevalence of rheumatic heart disease detected by echocardiographic screening. , 2007, The New England journal of medicine.

[5]  John D. Rose,et al.  Prevalence of rheumatic heart disease in children and young adults in Nicaragua. , 2010, The American journal of cardiology.

[6]  C. Mondo,et al.  Echocardiography Screening for Rheumatic Heart Disease in Ugandan Schoolchildren , 2012, Circulation.

[7]  S. Yusuf,et al.  Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). , 2014, European heart journal.

[8]  Beatriz Ferreira,et al.  World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease—an evidence-based guideline , 2012, Nature Reviews Cardiology.

[9]  J. Carapetis,et al.  Rare case of pericarditis constrictiva , 2005, Heart.

[10]  Dr B. J. Mitchell,et al.  Rheumatic Fever and Rheumatic Heart Disease , 1965 .

[11]  Cristian Pop-Eleches,et al.  Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders , 2011, AIDS.

[12]  P. Nordet WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from Phase I (1986-90). WHO Cardiovascular Diseases Unit and principal investigators. , 1992, Bulletin of the World Health Organization.

[13]  G. Rutherford,et al.  Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. , 2012, The Cochrane database of systematic reviews.

[14]  S. Padmavati,et al.  The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project. , 1981, Bulletin of the World Health Organization.

[15]  J. Carapetis,et al.  The global burden of group A streptococcal diseases. , 2005, The Lancet. Infectious diseases.

[16]  B. Mayosi,et al.  Rheumatic heart disease in Africa: the Mosi-o-Tunya call to action. , 2014, The Lancet. Global health.

[17]  J. Carapetis,et al.  Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease , 2013, Nature Reviews Cardiology.

[18]  J. Carapetis,et al.  Acute Rheumatic Fever and Rheumatic Heart Disease: Incidence and Progression in the Northern Territory of Australia, 1997 to 2010 , 2013, Circulation.

[19]  L. Zühlke,et al.  Estimates of the global burden of rheumatic heart disease. , 2013, Global heart.